Treating metastatic melanoma with Stereotactic Ablative Body Radiotherapy and IMmune Pathway ACTivation (SABR-IMPACT)

  • Senthi, Sashendra (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/1531/12/18

Funding

  • National Health and Medical Research Council (NHMRC) (Australia): AUD177,218.00